# pathway_0031: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0031.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Glycolipid biosynthesis

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MWSLDPSQKEVLRFAVSCRILTLMLQALFNIIIPDHHADAFSPPRLASSCSVDQLVEGLLGGLSRWDAEHFLFIAEHGYLYEHNFAFFPGFPLALLMGTELLRPLQGLLSQRSCLLVSVALLNFLFSVLAAVTLHDLGCLVLGCPRQAFYAAMLFCLSPANVFLAAGYSEALFAFLTFSAMGQLERGRSWASGLLFALATGVRSNGLVSVGFLLHAQCRGFFSSLVVLNPLKPLFKLMASLCLSVLTVSLPFALFQYYAYTQFCLPGSAHSVPEPLVQLAVDKGYRITGGNEPPWCSWGLPLVYSYIQDVYWNVGFLRYYELRQVPNFLLATPVAVLVVWAAWTYVTTHPWLCLTLGLRRSKDSKKTLEKPHPGFLSPKVFVYLVHAAGLLLFGSLCMHVQVLTRLLCSSTPVVYWFPAHLLQNQEPLLRSVDTVPEKLLEKNSPPGQKAPRNCIMKLLYNWRACSPVTRCILGYFLTYWLLGLLLHCNFLPWT

[Multiple Choices]
A. Amino-acid biosynthesis
B. L-valine biosynthesis
C. Glycolipid biosynthesis
D. Glycan degradation
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the Chinese hamster PIGV entry, whose pathway annotation includes glycolipid biosynthesis and GPI-anchor biosynthesis. The annotation cites a publication as evidence; the supplied excerpts do not independently establish the experimental details.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic and likely multipass membrane protein, but that does not identify its specific pathway or distinguish glycolipid biosynthesis from other membrane-associated functions.


**Missing item-specific fact**

> The protein-specific identity and functional annotation as PIGV, a GPI mannosyltransferase associated with glycolipid/GPI-anchor biosynthesis, are absent from the input.


**Reason**

> Choosing C depends on knowing this sequence's particular protein identity or equivalent external functional evidence; generic sequence features do not distinguish the listed pathways.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence supports C for this protein, although the sequence and choices alone do not provide a biological basis for selecting it.


### Important caveats

- The reviewer-only database record matches the sequence exactly; that identity information was not supplied to the evaluated model.
- The pathway annotation cites experimental literature, but the excerpts are database annotations rather than an independent review of the underlying experiments.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and likely multipass membrane protein, but that does not identify its specific pathway or distinguish glycolipid biosynthesis from other membrane-associated functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identity and functional annotation as PIGV, a GPI mannosyltransferase associated with glycolipid/GPI-anchor biosynthesis, are absent from the input.",
    "reason": "Choosing C depends on knowing this sequence's particular protein identity or equivalent external functional evidence; generic sequence features do not distinguish the listed pathways."
  },
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the Chinese hamster PIGV entry, whose pathway annotation includes glycolipid biosynthesis and GPI-anchor biosynthesis. The annotation cites a publication as evidence; the supplied excerpts do not independently establish the experimental details."
  },
  "important_caveats": [
    "The reviewer-only database record matches the sequence exactly; that identity information was not supplied to the evaluated model.",
    "The pathway annotation cites experimental literature, but the excerpts are database annotations rather than an independent review of the underlying experiments."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports C for this protein, although the sequence and choices alone do not provide a biological basis for selecting it."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the Chinese hamster PIGV entry, whose pathway annotation includes glycolipid biosynthesis and GPI-anchor biosynthesis. The annotation cites a publication as evidence; the supplied excerpts do not independently establish the experimental details.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and likely multipass membrane protein, but that does not identify its specific pathway or distinguish glycolipid biosynthesis from other membrane-associated functions.",
    "missing_item_specific_fact": "The protein-specific identity and functional annotation as PIGV, a GPI mannosyltransferase associated with glycolipid/GPI-anchor biosynthesis, are absent from the input.",
    "reason": "Choosing C depends on knowing this sequence's particular protein identity or equivalent external functional evidence; generic sequence features do not distinguish the listed pathways."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports C for this protein, although the sequence and choices alone do not provide a biological basis for selecting it."
  },
  "important_caveats": [
    "The reviewer-only database record matches the sequence exactly; that identity information was not supplied to the evaluated model.",
    "The pathway annotation cites experimental literature, but the excerpts are database annotations rather than an independent review of the underlying experiments."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A8C2M425 (PIGV_CRIGR, GPI alpha-1,6-mannosyltransferase 2) is explicitly annotated with pathway 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:23694781). The protein catalyzes mannosyl transfer in GPI-anchor assembly, a glycolipid biosynthesis pathway. The sequence matches exactly.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence encodes a ~494-residue protein with multiple transmembrane segments (at least 6-7 predicted TM helices), characteristic of ER-membrane-resident glycolipid biosynthetic enzymes. This multi-TM architecture strongly disfavors glycan degradation (D), which typically involves soluble lysosomal glycosidases. It also disfavors amino-acid biosynthesis (A), whose mammalian enzymes are soluble cytosolic/mitochondrial proteins. L-valine biosynthesis (B) is impossible in mammals since valine is an essential amino acid. The multi-TM ER membrane topology combined with mammalian origin provides a concrete biological argument favoring glycolipid biosynthesis (C) over all three alternatives.


**Missing item-specific fact**

> None strictly required. Precise identification as a GPI mannosyltransferase (GT4-family mannosyltransferase motif) would strengthen confidence, but the TM-domain topology and mammalian context already meaningfully distinguish C from the other choices.


**Reason**

> The multi-TM membrane architecture is a general, interpretable feature of the supplied sequence that aligns with ER glycolipid biosynthesis machinery rather than soluble degradation or amino-acid biosynthesis enzymes. The mammalian source eliminates valine biosynthesis as a biological impossibility. These are general biological arguments derivable from the sequence and context without needing to recall this specific protein's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four choices are well-separated by general biological reasoning: B is impossible in mammals, A involves soluble enzymes incompatible with multi-TM topology, and D involves lysosomal soluble enzymes. Only C is consistent with a multi-TM ER membrane glycolipid biosynthetic enzyme.


### Important caveats

- The pathway name in UniProt is 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis'; the option 'Glycolipid biosynthesis' is a valid abbreviation of this.
- The protein name annotation (GPI alpha-1,6-mannosyltransferase 2) is transferred by similarity (ECO:0000250 from Q9NUD9 human PIGV), but the pathway assignment is experimentally supported (ECO:0000269, PubMed:23694781).
- The multi-TM reasoning is a heuristic; a model without TM prediction tools might struggle to count helices accurately from raw sequence, though the hydrophobic stretches are visually apparent.
- The reviewer-only evidence confirms the key but was not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence encodes a ~494-residue protein with multiple transmembrane segments (at least 6-7 predicted TM helices), characteristic of ER-membrane-resident glycolipid biosynthetic enzymes. This multi-TM architecture strongly disfavors glycan degradation (D), which typically involves soluble lysosomal glycosidases. It also disfavors amino-acid biosynthesis (A), whose mammalian enzymes are soluble cytosolic/mitochondrial proteins. L-valine biosynthesis (B) is impossible in mammals since valine is an essential amino acid. The multi-TM ER membrane topology combined with mammalian origin provides a concrete biological argument favoring glycolipid biosynthesis (C) over all three alternatives.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required. Precise identification as a GPI mannosyltransferase (GT4-family mannosyltransferase motif) would strengthen confidence, but the TM-domain topology and mammalian context already meaningfully distinguish C from the other choices.",
    "reason": "The multi-TM membrane architecture is a general, interpretable feature of the supplied sequence that aligns with ER glycolipid biosynthesis machinery rather than soluble degradation or amino-acid biosynthesis enzymes. The mammalian source eliminates valine biosynthesis as a biological impossibility. These are general biological arguments derivable from the sequence and context without needing to recall this specific protein's database entry."
  },
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A8C2M425 (PIGV_CRIGR, GPI alpha-1,6-mannosyltransferase 2) is explicitly annotated with pathway 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:23694781). The protein catalyzes mannosyl transfer in GPI-anchor assembly, a glycolipid biosynthesis pathway. The sequence matches exactly."
  },
  "important_caveats": [
    "The pathway name in UniProt is 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis'; the option 'Glycolipid biosynthesis' is a valid abbreviation of this.",
    "The protein name annotation (GPI alpha-1,6-mannosyltransferase 2) is transferred by similarity (ECO:0000250 from Q9NUD9 human PIGV), but the pathway assignment is experimentally supported (ECO:0000269, PubMed:23694781).",
    "The multi-TM reasoning is a heuristic; a model without TM prediction tools might struggle to count helices accurately from raw sequence, though the hydrophobic stretches are visually apparent.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices are well-separated by general biological reasoning: B is impossible in mammals, A involves soluble enzymes incompatible with multi-TM topology, and D involves lysosomal soluble enzymes. Only C is consistent with a multi-TM ER membrane glycolipid biosynthetic enzyme."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A8C2M425 (PIGV_CRIGR, GPI alpha-1,6-mannosyltransferase 2) is explicitly annotated with pathway 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:23694781). The protein catalyzes mannosyl transfer in GPI-anchor assembly, a glycolipid biosynthesis pathway. The sequence matches exactly.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence encodes a ~494-residue protein with multiple transmembrane segments (at least 6-7 predicted TM helices), characteristic of ER-membrane-resident glycolipid biosynthetic enzymes. This multi-TM architecture strongly disfavors glycan degradation (D), which typically involves soluble lysosomal glycosidases. It also disfavors amino-acid biosynthesis (A), whose mammalian enzymes are soluble cytosolic/mitochondrial proteins. L-valine biosynthesis (B) is impossible in mammals since valine is an essential amino acid. The multi-TM ER membrane topology combined with mammalian origin provides a concrete biological argument favoring glycolipid biosynthesis (C) over all three alternatives.",
    "missing_item_specific_fact": "None strictly required. Precise identification as a GPI mannosyltransferase (GT4-family mannosyltransferase motif) would strengthen confidence, but the TM-domain topology and mammalian context already meaningfully distinguish C from the other choices.",
    "reason": "The multi-TM membrane architecture is a general, interpretable feature of the supplied sequence that aligns with ER glycolipid biosynthesis machinery rather than soluble degradation or amino-acid biosynthesis enzymes. The mammalian source eliminates valine biosynthesis as a biological impossibility. These are general biological arguments derivable from the sequence and context without needing to recall this specific protein's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices are well-separated by general biological reasoning: B is impossible in mammals, A involves soluble enzymes incompatible with multi-TM topology, and D involves lysosomal soluble enzymes. Only C is consistent with a multi-TM ER membrane glycolipid biosynthetic enzyme."
  },
  "important_caveats": [
    "The pathway name in UniProt is 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis'; the option 'Glycolipid biosynthesis' is a valid abbreviation of this.",
    "The protein name annotation (GPI alpha-1,6-mannosyltransferase 2) is transferred by similarity (ECO:0000250 from Q9NUD9 human PIGV), but the pathway assignment is experimentally supported (ECO:0000269, PubMed:23694781).",
    "The multi-TM reasoning is a heuristic; a model without TM prediction tools might struggle to count helices accurately from raw sequence, though the hydrophobic stretches are visually apparent.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt annotation places the protein in glycolipid biosynthesis, specifically GPI-anchor biosynthesis. The annotation identifies it as a GPI mannosyltransferase; the linked pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is strongly hydrophobic with many likely transmembrane helices, consistent with an ER membrane glycosyltransferase rather than a typical soluble amino-acid biosynthesis enzyme. Transferable knowledge of multipass GT-C glycosyltransferases supports sugar transfer during assembly of membrane-associated glycoconjugates, including glycolipids; glycan-degradation enzymes are more typically hydrolases. This makes C meaningfully more plausible than the offered alternatives, though the sequence architecture alone is not definitive.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence and transferable knowledge of membrane glycosyltransferase families give a credible, if probabilistic, basis for choosing glycolipid biosynthesis without needing the exact protein's database record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the offered choices, glycolipid biosynthesis best matches the inferred membrane glycosyltransferase function; no other option is comparably supported.


### Important caveats

- The multipass architecture is suggestive, not sufficient by itself to establish a specific pathway.
- The reviewer-only annotation supports the key, but its linked primary study was not independently examined.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic with many likely transmembrane helices, consistent with an ER membrane glycosyltransferase rather than a typical soluble amino-acid biosynthesis enzyme. Transferable knowledge of multipass GT-C glycosyltransferases supports sugar transfer during assembly of membrane-associated glycoconjugates, including glycolipids; glycan-degradation enzymes are more typically hydrolases. This makes C meaningfully more plausible than the offered alternatives, though the sequence architecture alone is not definitive.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence and transferable knowledge of membrane glycosyltransferase families give a credible, if probabilistic, basis for choosing glycolipid biosynthesis without needing the exact protein's database record."
  },
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation places the protein in glycolipid biosynthesis, specifically GPI-anchor biosynthesis. The annotation identifies it as a GPI mannosyltransferase; the linked pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here."
  },
  "important_caveats": [
    "The multipass architecture is suggestive, not sufficient by itself to establish a specific pathway.",
    "The reviewer-only annotation supports the key, but its linked primary study was not independently examined."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the offered choices, glycolipid biosynthesis best matches the inferred membrane glycosyltransferase function; no other option is comparably supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation places the protein in glycolipid biosynthesis, specifically GPI-anchor biosynthesis. The annotation identifies it as a GPI mannosyltransferase; the linked pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic with many likely transmembrane helices, consistent with an ER membrane glycosyltransferase rather than a typical soluble amino-acid biosynthesis enzyme. Transferable knowledge of multipass GT-C glycosyltransferases supports sugar transfer during assembly of membrane-associated glycoconjugates, including glycolipids; glycan-degradation enzymes are more typically hydrolases. This makes C meaningfully more plausible than the offered alternatives, though the sequence architecture alone is not definitive.",
    "missing_item_specific_fact": "",
    "reason": "The sequence and transferable knowledge of membrane glycosyltransferase families give a credible, if probabilistic, basis for choosing glycolipid biosynthesis without needing the exact protein's database record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the offered choices, glycolipid biosynthesis best matches the inferred membrane glycosyltransferase function; no other option is comparably supported."
  },
  "important_caveats": [
    "The multipass architecture is suggestive, not sufficient by itself to establish a specific pathway.",
    "The reviewer-only annotation supports the key, but its linked primary study was not independently examined."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this exact sequence (A0A8C2M425, PIGV_CRIGR) explicitly annotates the pathway as 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' with experimental evidence (ECO:0000269|PubMed:23694781, Hirata et al. J. Biochem. 2013). The protein is GPI alpha-1,6-mannosyltransferase 2 (PIGV/GPI-MT-II), a mannosyltransferase in the GPI-anchor biosynthetic pathway. This directly supports choice C.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 494-residue sequence exhibits an extreme multi-transmembrane topology (approximately 8–10+ hydrophobic stretches spanning the sequence), characteristic of integral ER-membrane proteins involved in lipid/glycan biosynthesis (e.g., PIG enzymes, ceramide synthases, glucosylceramide synthase). This topology allows direct interaction with membrane-embedded lipid substrates (dolichol-phosphate mannose, GPI intermediates). In contrast: (A) amino-acid biosynthesis enzymes are soluble cytoplasmic enzymes (e.g., synthases, transaminases) without multi-TM architecture; (B) L-valine biosynthesis is a bacterial/fungal pathway absent in mammals, and its enzymes are also soluble; (D) glycan-degradation enzymes (glycosidases) are typically soluble cytosolic/lysosomal or single-pass membrane proteins, not 8+ TM integral membrane proteins. Thus, the pronounced multi-TM hydrophobic architecture plus glycosyltransferase-like conserved motifs (e.g., regions resembling DxH or HxxxD motifs common in retaining glycosyltransferases) meaningfully favor C (Glycolipid biosynthesis) over A, B, and D using general knowledge of membrane-protein topology and pathway compartmentalization learned from many other ER biosynthetic enzymes.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The multi-TM topology visible directly from the sequence, combined with general knowledge that ER-membrane glycolipid biosynthetic enzymes are multi-pass integral membrane proteins while amino-acid biosynthesis enzymes and glycan-degradation glycosidases are soluble or single-pass, provides a concrete transferable inference that distinguishes C from the other three options without needing to recall this specific protein's database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The extreme multi-TM hydrophobicity of the sequence clearly excludes soluble-enzyme pathways (A, B) and typical glycosidase topology (D). Among the four offered choices, only C is consistent with an 8+ TM ER-membrane glycosyltransferase. No other option is genuinely defensible given the sequence architecture.


### Important caveats

- The UniProt annotation for GPI-MT-II relies partly on similarity-based transfer (ECO:0000250|UniProtKB:Q9NUD9) for the name and pathway assignment, though the experimental paper (PubMed:23694781) independently confirmed the mannosyltransferase activity and pathway role.
- The organism (Chinese hamster) is not provided in the original user input; however, the multi-TM topology argument does not depend on knowing the species.
- The sequence is 494 residues; the hydrophobicity profile is directly computable from the provided sequence without external lookup.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 494-residue sequence exhibits an extreme multi-transmembrane topology (approximately 8–10+ hydrophobic stretches spanning the sequence), characteristic of integral ER-membrane proteins involved in lipid/glycan biosynthesis (e.g., PIG enzymes, ceramide synthases, glucosylceramide synthase). This topology allows direct interaction with membrane-embedded lipid substrates (dolichol-phosphate mannose, GPI intermediates). In contrast: (A) amino-acid biosynthesis enzymes are soluble cytoplasmic enzymes (e.g., synthases, transaminases) without multi-TM architecture; (B) L-valine biosynthesis is a bacterial/fungal pathway absent in mammals, and its enzymes are also soluble; (D) glycan-degradation enzymes (glycosidases) are typically soluble cytosolic/lysosomal or single-pass membrane proteins, not 8+ TM integral membrane proteins. Thus, the pronounced multi-TM hydrophobic architecture plus glycosyltransferase-like conserved motifs (e.g., regions resembling DxH or HxxxD motifs common in retaining glycosyltransferases) meaningfully favor C (Glycolipid biosynthesis) over A, B, and D using general knowledge of membrane-protein topology and pathway compartmentalization learned from many other ER biosynthetic enzymes.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The multi-TM topology visible directly from the sequence, combined with general knowledge that ER-membrane glycolipid biosynthetic enzymes are multi-pass integral membrane proteins while amino-acid biosynthesis enzymes and glycan-degradation glycosidases are soluble or single-pass, provides a concrete transferable inference that distinguishes C from the other three options without needing to recall this specific protein's database annotation."
  },
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this exact sequence (A0A8C2M425, PIGV_CRIGR) explicitly annotates the pathway as 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' with experimental evidence (ECO:0000269|PubMed:23694781, Hirata et al. J. Biochem. 2013). The protein is GPI alpha-1,6-mannosyltransferase 2 (PIGV/GPI-MT-II), a mannosyltransferase in the GPI-anchor biosynthetic pathway. This directly supports choice C."
  },
  "important_caveats": [
    "The UniProt annotation for GPI-MT-II relies partly on similarity-based transfer (ECO:0000250|UniProtKB:Q9NUD9) for the name and pathway assignment, though the experimental paper (PubMed:23694781) independently confirmed the mannosyltransferase activity and pathway role.",
    "The organism (Chinese hamster) is not provided in the original user input; however, the multi-TM topology argument does not depend on knowing the species.",
    "The sequence is 494 residues; the hydrophobicity profile is directly computable from the provided sequence without external lookup."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The extreme multi-TM hydrophobicity of the sequence clearly excludes soluble-enzyme pathways (A, B) and typical glycosidase topology (D). Among the four offered choices, only C is consistent with an 8+ TM ER-membrane glycosyltransferase. No other option is genuinely defensible given the sequence architecture."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0031",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this exact sequence (A0A8C2M425, PIGV_CRIGR) explicitly annotates the pathway as 'Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis' with experimental evidence (ECO:0000269|PubMed:23694781, Hirata et al. J. Biochem. 2013). The protein is GPI alpha-1,6-mannosyltransferase 2 (PIGV/GPI-MT-II), a mannosyltransferase in the GPI-anchor biosynthetic pathway. This directly supports choice C.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 494-residue sequence exhibits an extreme multi-transmembrane topology (approximately 8–10+ hydrophobic stretches spanning the sequence), characteristic of integral ER-membrane proteins involved in lipid/glycan biosynthesis (e.g., PIG enzymes, ceramide synthases, glucosylceramide synthase). This topology allows direct interaction with membrane-embedded lipid substrates (dolichol-phosphate mannose, GPI intermediates). In contrast: (A) amino-acid biosynthesis enzymes are soluble cytoplasmic enzymes (e.g., synthases, transaminases) without multi-TM architecture; (B) L-valine biosynthesis is a bacterial/fungal pathway absent in mammals, and its enzymes are also soluble; (D) glycan-degradation enzymes (glycosidases) are typically soluble cytosolic/lysosomal or single-pass membrane proteins, not 8+ TM integral membrane proteins. Thus, the pronounced multi-TM hydrophobic architecture plus glycosyltransferase-like conserved motifs (e.g., regions resembling DxH or HxxxD motifs common in retaining glycosyltransferases) meaningfully favor C (Glycolipid biosynthesis) over A, B, and D using general knowledge of membrane-protein topology and pathway compartmentalization learned from many other ER biosynthetic enzymes.",
    "missing_item_specific_fact": "",
    "reason": "The multi-TM topology visible directly from the sequence, combined with general knowledge that ER-membrane glycolipid biosynthetic enzymes are multi-pass integral membrane proteins while amino-acid biosynthesis enzymes and glycan-degradation glycosidases are soluble or single-pass, provides a concrete transferable inference that distinguishes C from the other three options without needing to recall this specific protein's database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The extreme multi-TM hydrophobicity of the sequence clearly excludes soluble-enzyme pathways (A, B) and typical glycosidase topology (D). Among the four offered choices, only C is consistent with an 8+ TM ER-membrane glycosyltransferase. No other option is genuinely defensible given the sequence architecture."
  },
  "important_caveats": [
    "The UniProt annotation for GPI-MT-II relies partly on similarity-based transfer (ECO:0000250|UniProtKB:Q9NUD9) for the name and pathway assignment, though the experimental paper (PubMed:23694781) independently confirmed the mannosyltransferase activity and pathway role.",
    "The organism (Chinese hamster) is not provided in the original user input; however, the multi-TM topology argument does not depend on knowing the species.",
    "The sequence is 494 residues; the hydrophobicity profile is directly computable from the provided sequence without external lookup."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A8C2M425",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "9d3f46ba22c4115b7a8c603ef5a943e2972a8c829daba3e4cf44f5137f9c98a1",
  "benchmark_sequence_length": 494,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 21,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2022-01-19",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "current_source_sequence_sha256": "9d3f46ba22c4115b7a8c603ef5a943e2972a8c829daba3e4cf44f5137f9c98a1",
  "current_source_sequence_length": 494,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 19,
  "selected_historical_version": {
    "accession": "A0A8C2M425",
    "database": "Swiss-Prot",
    "entryVersion": 19,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "PIGV_CRIGR",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "3a921910821c09b2eb30c40b3d3667f24af1b35f453619bbd6c349c529666aef",
  "selected_historical_source_sequence_sha256": "9d3f46ba22c4115b7a8c603ef5a943e2972a8c829daba3e4cf44f5137f9c98a1",
  "selected_historical_source_sequence_length": 494,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 19,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A8C2M425\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":21,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2022-01-19\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Chinese hamster\",\"lineage\":[\"Eukaryota\",\"Metazoa\",\"Chordata\",\"Craniata\",\"Vertebrata\",\"Euteleostomi\",\"Mammalia\",\"Eutheria\",\"Euarchontoglires\",\"Glires\",\"Rodentia\",\"Myomorpha\",\"Muroidea\",\"Cricetidae\",\"Cricetinae\",\"Cricetulus\"],\"scientificName\":\"Cricetulus griseus\",\"synonyms\":[\"Cricetulus barabensis griseus\"],\"taxonId\":10029}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"value\":\"GPI mannosyltransferase II\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"Q9NUD9\",\"source\":\"UniProtKB\"}],\"value\":\"GPI-MT-II\"}]},{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"Q9NUD9\",\"source\":\"UniProtKB\"}],\"value\":\"Phosphatidylinositol-glycan biosynthesis class V protein\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"Q9NUD9\",\"source\":\"UniProtKB\"}],\"value\":\"PIG-V\"}]}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"23694781\",\"source\":\"PubMed\"}],\"value\":\"2.4.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"Q9NUD9\",\"source\":\"UniProtKB\"}],\"value\":\"GPI alpha-1,6-mannosyltransferase 2\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"23694781\",\"source\":\"PubMed\"}],\"value\":\"Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A8C2M425.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A8C2M425.json",
  "source_sha256": "4ac1d4befce2ad1aed32c8b789b20db35cf03975e9e81d35460677c7af7b77aa",
  "retrieved_utc": "2026-11-02T04:25:57.236271+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Hirata T.\",\"Fujita M.\",\"Kanzawa N.\",\"Murakami Y.\",\"Maeda Y.\",\"Kinoshita T.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"23694781\"},{\"database\":\"DOI\",\"id\":\"10.1093/jb/mvt045\"}],\"citationType\":\"journal article\",\"firstPage\":\"257\",\"id\":\"23694781\",\"journal\":\"J. Biochem.\",\"lastPage\":\"264\",\"publicationDate\":\"2013\",\"title\":\"Glycosylphosphatidylinositol mannosyltransferase II is the rate-limiting enzyme in glycosylphosphatidylinositol biosynthesis under limited dolichol-phosphate mannose availability.\",\"volume\":\"154\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19",
  "source_sha256": "3a921910821c09b2eb30c40b3d3667f24af1b35f453619bbd6c349c529666aef",
  "retrieved_utc": "2026-11-02T04:26:00.136470+00:00",
  "source_locator": "lines 1-17",
  "excerpt": "ID   PIGV_CRIGR              Reviewed;         494 AA.\nAC   A0A8C2M425;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   19-JAN-2022, sequence version 1.\nDT   28-JAN-2026, entry version 19.\nDE   RecName: Full=GPI alpha-1,6-mannosyltransferase 2 {ECO:0000250|UniProtKB:Q9NUD9};\nDE            EC=2.4.1.- {ECO:0000269|PubMed:23694781};\nDE   AltName: Full=GPI mannosyltransferase II;\nDE            Short=GPI-MT-II {ECO:0000250|UniProtKB:Q9NUD9};\nDE   AltName: Full=Phosphatidylinositol-glycan biosynthesis class V protein {ECO:0000250|UniProtKB:Q9NUD9};\nDE            Short=PIG-V {ECO:0000250|UniProtKB:Q9NUD9};\nGN   Name=PIGV {ECO:0000303|PubMed:23694781};\nOS   Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus).\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;\nOC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea;\nOC   Cricetidae; Cricetinae; Cricetulus.\nOX   NCBI_TaxID=10029;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19",
  "source_sha256": "3a921910821c09b2eb30c40b3d3667f24af1b35f453619bbd6c349c529666aef",
  "retrieved_utc": "2026-11-02T04:26:00.136470+00:00",
  "source_locator": "lines 28-35",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.\nRX   PubMed=23694781; DOI=10.1093/jb/mvt045;\nRA   Hirata T., Fujita M., Kanzawa N., Murakami Y., Maeda Y., Kinoshita T.;\nRT   \"Glycosylphosphatidylinositol mannosyltransferase II is the rate-limiting\nRT   enzyme in glycosylphosphatidylinositol biosynthesis under limited dolichol-\nRT   phosphate mannose availability.\";\nRL   J. Biochem. 154:257-264(2013).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A8C2M425?format=txt&versions=19",
  "source_sha256": "3a921910821c09b2eb30c40b3d3667f24af1b35f453619bbd6c349c529666aef",
  "retrieved_utc": "2026-11-02T04:26:00.136470+00:00",
  "source_locator": "lines 75-76",
  "excerpt": "CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor\nCC       biosynthesis. {ECO:0000269|PubMed:23694781}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 31. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
